Middle East Healthcare Company — Cyborg Score 7/10
Strong
Healthcare Services / Hospitals
Strategic Profile
The company operates three primary revenue segments: inpatient services, outpatient services, and pharmacy sales. With strong financial momentum—2023 revenue reached 2.65 billion SAR (23.3% YoY growth) and net earnings surged 139.65% to 180.18 million SAR—the company demonstrates solid operational scaling. The company is positioned as a premium healthcare provider under the established Saudi German Hospital brand, with a diversified footprint across the MENA region and a subsidiary relationship with Bait Al Batterjee Medical Co.
Cyborg Score Rationale
Solid financial growth trajectory with significant margin expansion, established multi-country presence, and consistent dividend payouts. Recent stock volatility (52-week range 37.66-84.80 SAR) suggests market uncertainty despite strong fundamentals. The company's large employee base (4,220 staff) and patient volume indicate operational maturity.
Top Insights
Revenue grew 23.3% YoY to 2.65B SAR in 2023 with earnings jumping 139.65%, indicating strong operational leverage and margin expansion
Operates 13 hospitals serving 2.5M+ patients annually across MENA, positioning it as a major regional healthcare provider
Stock trading at 38.00 SAR (Dec 2025) reflects 55% decline from 52-week high of 84.80, despite solid fundamentals and 1.32% dividend yield
Three-segment revenue model (inpatient, outpatient, pharmacy) provides diversification and multiple growth levers in high-growth healthcare markets
Named Competitors
Mouwasat Healthcare — Major Saudi hospital chain and emergency care provider
Sulaiman AlHabib Medical Services — Premium tertiary care hospitals across Saudi Arabia
Dallah Healthcare Services — Integrated healthcare provider with hospital network
Recent Developments
(Dec 2025) Stock trading at 38.00 SAR with dividend yield of 1.32%, significantly below 52-week high of 84.80 SAR
(2023) Revenue reached 2.65B SAR (+23.3% YoY) with net earnings of 180.18M SAR (+139.65% YoY)
(Jan 2026) Market capitalization of approximately 3.50B SAR based on latest valuation metrics
Open the full interactive Middle East Healthcare Company report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.